Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
Houreratou Barry and co-workers report on safety and immunogenicity of an Ebola vaccine in adults across four African countries.